Pfizer Inc. Stays Mum As Newly Appointed Drug Unit Head Exits Abruptly
Pfizer Inc. (PFE)’s Amy Schulman, named to head one of the company’s three new drug units starting next month, will instead leave the company. Schulman, a deputy to Chief Executive Officer Ian Read and Pfizer’s general counsel, was chosen in July to lead one of the businesses as the New York-based company reorganized ahead of a potential breakup. Albert Bourla, a 20-year Pfizer veteran, will now head the unit, which handles vaccines, oncology and consumer health products, Pfizer said in a statement today.
Help employers find you! Check out all the jobs and post your resume.